Search by Drug Name or NDC
NDC 50090-4969-02 Benzonatate 100 mg/1 Details
Benzonatate 100 mg/1
Benzonatate is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by A-S Medication Solutions. The primary component is BENZONATATE.
MedlinePlus Drug Summary
Benzonatate is used to relieve cough. Benzonatate is in a class of medications called antitussives (cough suppressants). It works by reducing the cough reflex in the lungs and air passages.
Related Packages: 50090-4969-02Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Benzonatate
Product Information
| NDC | 50090-4969 |
|---|---|
| Product ID | 50090-4969_39ef94b2-c7cc-45c6-8f62-720e4928a659 |
| Associated GPIs | 43102010000105 |
| GCN Sequence Number | 004641 |
| GCN Sequence Number Description | benzonatate CAPSULE 100 MG ORAL |
| HIC3 | H6C |
| HIC3 Description | ANTITUSSIVES, NON-OPIOID |
| GCN | 29840 |
| HICL Sequence Number | 001929 |
| HICL Sequence Number Description | BENZONATATE |
| Brand/Generic | Generic |
| Proprietary Name | Benzonatate |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Benzonatate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | CAPSULE |
| Route | ORAL |
| Active Ingredient Strength | 100 |
| Active Ingredient Units | mg/1 |
| Substance Name | BENZONATATE |
| Labeler Name | A-S Medication Solutions |
| Pharmaceutical Class | Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA202765 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 50090-4969-02 (50090496902)
| NDC Package Code | 50090-4969-2 |
|---|---|
| Billing NDC | 50090496902 |
| Package | 30 CAPSULE in 1 BOTTLE (50090-4969-2) |
| Marketing Start Date | 2020-03-17 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |